These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7750588

  • 1. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome.
    Lanzone A, Petraglia F, Fulghesu AM, Ciampelli M, Caruso A, Mancuso S.
    Fertil Steril; 1995 Jun; 63(6):1195-9. PubMed ID: 7750588
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S.
    Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
    [Abstract] [Full Text] [Related]

  • 3. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 4. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.
    Ciampelli M, Guido M, Cucinelli F, Cinque B, Barini A, Lanzone A.
    Fertil Steril; 2000 Apr; 73(4):712-7. PubMed ID: 10731530
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R, Faggiano A, Filippella M, Di Somma C, De Martino MC, Gaccione M, Lombardi G, Colao A.
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [Abstract] [Full Text] [Related]

  • 7. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
    Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
    [Abstract] [Full Text] [Related]

  • 8. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 9. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 10. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
    Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F.
    Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
    [Abstract] [Full Text] [Related]

  • 11. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R, Ishai A, Shen-Or Z, Herer P.
    Neuro Endocrinol Lett; 2003 Mar; 24(3-4):249-54. PubMed ID: 14523365
    [Abstract] [Full Text] [Related]

  • 13. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J, Balm PH, Ruane NM, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of the hypothalamic-pituitary-adrenal axis with corticotropin releasing hormone in patients with psoriasis.
    Karanikas E, Harsoulis F, Giouzepas I, Griveas I.
    Hormones (Athens); 2007 Aug; 6(4):314-20. PubMed ID: 18055422
    [Abstract] [Full Text] [Related]

  • 15. Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's disease.
    Cannavò S, Li Calzi L, Aragona A, Trimarchi F.
    J Endocrinol Invest; 1988 Jun; 11(6):425-8. PubMed ID: 2850311
    [Abstract] [Full Text] [Related]

  • 16. The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome.
    Stewart PM, Penn R, Holder R, Parton A, Ratcliffe JG, London DR.
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):387-91. PubMed ID: 8391404
    [Abstract] [Full Text] [Related]

  • 17. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.
    Sasaki A, Shinkawa O, Yoshinaga K.
    J Clin Invest; 1989 Dec; 84(6):1997-2001. PubMed ID: 2556451
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 19. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [Abstract] [Full Text] [Related]

  • 20. Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.
    Invitti C, De Martin M, Delitala G, Veldhuis JD, Cavagnini F.
    Metabolism; 1998 Feb; 47(2):143-8. PubMed ID: 9472960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.